Tandem Diabetes Care, Inc. (LON:0M0F)
London flag London · Delayed Price · Currency is GBP · Price in USD
34.19
+0.80 (2.38%)
At close: Feb 18, 2025

Tandem Diabetes Care Revenue

Tandem Diabetes Care had revenue of $243.97M USD in the quarter ending September 30, 2024, with 31.43% growth. This brings the company's revenue in the last twelve months to $854.35M, up 10.75% year-over-year. In the year 2023, Tandem Diabetes Care had annual revenue of $747.72M, down -6.68%.

Revenue (ttm)
$854.35M
Revenue Growth
+10.75%
P/S Ratio
n/a
Revenue / Employee
$355.98K
Employees
2,400
Market Cap
1.61B GBP

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023747.72M-53.50M-6.68%
Dec 31, 2022801.22M98.42M14.00%
Dec 31, 2021702.80M203.97M40.89%
Dec 31, 2020498.83M136.53M37.68%
Dec 31, 2019362.31M178.44M97.05%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 43.19B
Shell 227.10B
HSBC Holdings 48.93B
Unilever 50.25B
Rio Tinto Group 42.86B
RELX PLC 9.43B
BP p.l.c. 149.68B
British American Tobacco p.l.c. 25.87B
Revenue Rankings